21181 ⎘
Medicinal preparations containing antigens or antibodies characterised by the route of administration; Mucosal route intranasal
Vault compositions for immunization against Chlamydia genital infection
#602Temperature sensitive vaccine strain of and uses thereof
#603Vaccine Compositions
#604NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES
#605Mucosal Immunization
#606Influenza vaccine, composition, and methods of use
#607HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS
#608NUCLEIC ACID MUCOSAL IMMUNIZATION
#609Recombinant HIV-1 envelope proteins comprising stabilizing two-cysteine mini-domains in gp41
#610Multivalent nanoemulsion vaccines
#611Compositions and methods for treatment of microbial infections
#612NOROVIRUS VACCINE FORMULATIONS
#613Use of antigen
#614Chlamydia antigens
#615Method for prophylaxis of influenza using vaccine for intranasal administration
#616Compositions and methods for treating of microbial infections
#617Treatment of allergic otitis media in mammals with neurotoxins
#618Methods for preparing and delivering adjuvant compositions
#619PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#620CROSS-PROTECTIVE INFLUENZA VACCINE
#621RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#622Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
#623Poultry viral materials and methods related thereto
#624INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#625Antigen delivery vectors and constructs
#626Dose selection of adjuvanted synthetic nanocarriers
#627NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES
#628Methods and compositions for immunizing against infection
#629Respiratory syncytial virus antigenic compositions and methods
#630Influenza hemagglutinin and neuraminidase variants
#631VACCINE AGAINST BOTULISM
#632Gp41 antigens
#633Splitting GP41
#634SYNTHETIC NANOCARRIER COMBINATION VACCINES
#635MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
#636NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT
#637Porcine Adenovirus 3-Based PRRSV Vaccines
#638Influenza virus-like particles (VLPS) comprising hemagglutinin
#639Equine disease model for herpesvirus neurologic disease and uses thereof
#640Cancer vaccine compositions and methods of using the same
#641IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES
#642vectored vaccines against and methods of use
#643SINGLE-TIME VACCINES
#644Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
#645Vaccines comprising mutant attenuated influenza viruses
#646LIGANDS THAT BIND IL-13
#647COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING URINARY TRACT INFECTIONS
#648dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
#649Mucosal and Systemic Immunization with Alphavirus Replicon Particles
#650VACCINE
#651Live, attenuated respiratory syncytial virus
#652MUCOSAL VACCINE USING CATIONIC NANOGEL
#653Synergistic immunogenic fusion protein-polysaccharide conjugate
#654Prevention and treatment of gram negative, flagellated bacterial infections
#655Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
#656Influenza virus immunizing epitope
#657RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
#658Method of conferring a protective immune response to norovirus
#659Influenza hemagglutinin and neuraminidase variants
#660Multi-component L2 vaccine for prevention of human papilloma virus infection
#661Novel Compositions and Adjuvants
#662Tat DNA sequences, gene constructs, vaccine and processes thereof
#663Method and composition for delivery of medicants to animals
#664METHOD AND COMPOSITION FOR DELIVERY OF MEDICANTS TO ANIMALS
#665West Nile Virus vaccine
#666Compositions and methods for diagnosing and treating urinary tract infections
#667METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#668Treatment of sinusitis in mammals with clostridia neurotoxins
#669INFLUENZA VACCINES
#670MUCOSAL MENINGOCOCCAL VACCINES
#671Avian influenza virus live attenuated vaccine and uses thereof
#672Yeast-based vaccines as immunotherapy
#673MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE
#674Methods and compositions for enhanced delivery of macromolecules
#675Adenoviral-based vectors
#676POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES
#677Recombinant antigen
#678Methods and compositions for immunization against chlamydial infection and disease
#679Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
#680Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines
#681POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO
#682Treatment of asthma in mammals with clostridia neurotoxins
#683Treatment of allergic rhinitis in mammals with neurotoxins
#684Recombinant Rhinovirus Vectors
#685NOVEL VACCINE FOR DOG
#686Treatment of infectious rhinitis in mammals with clostridia neurotoxins
#687Chimeric adenoviral vectors
#688Influenza A virus with attenuating mutations in NS2 protein
#689DOUBLE-LABELLING AGENTS BASED ON VINYL SULPHONE
#690Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
#691E-selectin compositions and use thereof for inducing E-selectin tolerance
#692Recombinant Double-Stranded RNA Phage, and Use of the Same
#693Influenza hemagglutinin and neuraminidase variants
#694Baculovirus expression vector and method therewith for generating immunogenicity in a host
#695HIV VACCINE FOR MUCOSAL DELIVERY
#696-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#697VACCINE
#698COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES
#699Human respiratory syncytial virus (RSV) vaccine
#700VACCINE TARGETS AND DELIVERY SYSTEMS FOR CRYPTOSPORIDIUM
#701Alphavirus Vectors for Respiratory Pathogen Vaccines
#702Use of for prevention and treatment of allergic airway disorders
#703IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#704HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES
#705Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
#706NANOEMULSION VACCINES
#707RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ
#708Live Attenuated Vaccine Strain for Prevention of Tularemia
#709Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#710Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
#711Immunoprotective influenza antigen and its use in vaccination
#712ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION
#713Respiratory syncytial virus with a genomic deficiency complemented in trans
#714COMBINED MUCOSAL AND PARENTERAL IMMUNIZATION AGAINST HIV
#715Use of flagellin in the immunotherapy of
#716NASAL-ADMINISTERED VACCINES USING MULTI-SCREENED NALT-TARGETING AND PHAGOCYTIC POLYPEPTIDE TRANSPORT SEQUENCES
#717Vaccine for viruses that cause persistent or latent infections
#718METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS
#719AIDS virus vaccines using Sendai virus vector
#720Newcastle disease virus vectored avian vaccines
#721Cholera vaccines
#722INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT
#723Recombinant Rhinovirus Vectors
#724NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#725Recombinant baculovirus vaccine
#726IMMUNE RESPONSE INDUCTION METHOD
#727Yeast-Based Vaccine for Inducing an Immune Response
#728Functional Mutations In Respiratory Syncytial Virus
#729Antigen delivery vectors and constructs
#730Antigen delivery vectors and constructs
#731Adjuvant compositions and methods of use
#732Method for viral inoculation of the vestibular region of the nares
#733HLA-A2-RESTRICTED T-CELL EPITOPES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN AS PEPTIDE-BASED VACCINES
#734Method of inducing immune tolerance to type I diabetes
#735Secretory IgA and IgG Antibody Inducer
#736ADMINISTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES
#737ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#738Compositions and methods for treating microbial infections
#739Vaccine against pandemic strains of influenza viruses
#740IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA
#741Immunotherapy of virus infection
#742Functional influenza virus like particles (VLPs)
#743hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
#744IMMUNOGENIC MOLECULES
#745INTRANASAL DELIVERY OF POLYPEPTIDES AND PROTEINS
#746Use of invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
#747RSV F-protein and its use
#748N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#749ENHANCING DISEASE RESISTANCE AGAINST RNA VIRAL INFECTIONS WITH INTRACYTOPLASMIC PATHOGEN SENSORS
#750METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#751Immunogenic lipopeptides comprising T-helper and B-cell epitopes
#752Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
#753Chimeric influenza virus-like particles
#754H3 equine influenza A virus
#755Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
#756Novel Vaccination Carrier
#757CHIMERIC VIRUS-LIKE PARTICLES
#758Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
#759Vaccine formulation
#760Uses for Yerba Santa
#761Vaccines for the Rapid Response to Pandemic Avian Influenza
#762Flu vaccine admixture of mannan and flu antigen
#763Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus
#764Compositions and methods for treatment of microbial infections
#765Recombinant baculovirus vaccine
#766Neuraminidase-deficient live influenza vaccines
#767FILAMENTOUS BACTERIOPHAGE DISPLAYING PROTEIN AS A BINDER OF ANTIBODIES AND IMMUNOCOMPLEXES FOR DELIVERY TO THE BRAIN
#768Signal for packaging of influenza virus vectors
#769Recombinant double stranded RNA nucleocapsid and use of the same
#770Nanoemulsion influenza vaccine
#771Vault compositions for immunization against chlamydia genital infection
#772Influenza vaccine
#773Inactivated influenza virus compositions
#774based oral vaccines for anthrax
#775NANOEMULSION ADJUVANTS
#776Prevention of allergy in children
#777Recombinant RSV Virus Expression Systems And Vaccines
#778METHODS AND COMPOUNDS FOR MITIGATING PATHOGENIC OUTBREAKS USING REPLIKIN COUNT CYCLES
#779NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT
#780Live attenuated strains as a single dose vaccine against whooping cough
#781Porcine circovirus type 2 vaccines
#782Recombinant mononegaviral virus vectors
#783Nasal Vaccine
#784Methods and compositions for immunizing against infection
#785Compositions comprising chitin microparticles and their medical uses
#786Multi plasmid system for the production of influenza virus
#787Methods for the propagation of modified influenza viruses in embryonated eggs
#788Cloned defective interfering influenza A virus
#789Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
#790Treatment of CNS conditions
#791Influenza hemagglutinin and neuraminidase variants
#792MEASLES SUBUNIT VACCINE
#793SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#794Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
#795INFLUENZA COMBINATORIAL ANTIGEN VACCINE
#796VACCINE FOR RSV AND MPV
#797Novel vaccine
#798Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
#799Microbial vaccine and vaccine vector
#800Induction of mucosal tolerance to antigens
#801Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic
#802Influenza hemagglutinin and neuraminidase variants
#803IMMUNIZATION-FREE METHODS FOR TREATING ANTIGEN-STIMULATED INFLAMMATION IN A MAMMALIAN HOST AND SHIFTING THE HOST'S ANTIGEN IMMUNE RESPONSIVENESS TO A TH1 PHENOTYPE
#804vaccine and methods of use thereof
#805Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
#806Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#807Functional Mutations In Respiratory Syncytial Virus
#808Recombinant flu vaccines
#809Influenza Virus Vaccine
#810Alphavirus Vectors for Respiratory Pathogen Vaccines
#811Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations
#812Methods and compositions for immunization against chlamydial infection and disease
#813PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#814HIV VACCINE FOR MUCOSAL DELIVERY
#815Immunogenic compositions and methods
#816Influenza M2 protein mutant viruses as live influenza attenuated vaccines
#817Compositions and methods for diagnosing and treating urinary tract infections
#818Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
#819Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#820Compositions and methods for transepithelial molecular transport
#821Intranasal vaccine for use against disease caused by enterotoxigenic
#822Polyvalent influenza virus-like particle (VLP) compositions
#823Human papillomavirus vaccine for oral administration
#824Vaccine Composition Comprising Alpha-Galactosylceramide as an Adjuvant For Intranasal Administration
#825Biomarkers of infection
#826Attenuated influenza virus and a live vaccine comprising the same
#827Norovirus vaccine formulations
#828Methods and compositions involving polymeric immunoglobulin fusion proteins
#829Recombinant RSV Virus Expression Systems And Vaccines
#830PROTEOSOME INFLUENZA VACCINE
#831Vaccines for immunization against helicobacter
#832Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
#833Artificial invaplex
#834VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS
#835Methods and compositions for treating IgE-mediated diseases
#836Treatment and prevention of vascular dementia
#837Method and composition for delivery of medicants to animals
#838SUBUNIT VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS INFECTION
#839Mutated heat-labile enterotoxin
#840Use of Flagellin in Tumor Immunotherapy
#841Method for producing storage stable viruses and immunogenic compositions thereof
#842Compositions and methods for treatment of microbial infections
#843Vaccine Against Pandemic Strains Of Influenza Viruses
#844Immunstimulating lipid formulation
#845Vaccine delivery compositions and methods of use
#846Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
#847Use of flagellin in the immunotherapy of
#848Sphingolipids' polyalkylamines conjugates
#849Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
#850CHLAMYDIA VACCINES
#851Mutated heat-labile enterotoxin
#852Attenuated parainfluenza virus (PIV) vaccines
#853Immunological combination compositions and methods
#854Influenza Hemagglutinin And Neuraminidase Variants
#855Influenza hemagglutinin and neuraminidase variants
#856METHODS FOR PREPARING AND DELIVERING ADJUVANT COMPOSITIONS
#857Intranasal or inhalational administration of virosomes
#858PREVENTION OF ALLERGY IN CHILDREN
#859Influenza virus-like particle (VLP) compositions
#860Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors
#861Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
#862Cysteine-rich region of respiratory syncytial virus and methods of use therefor
#863Yeast-based vaccine for inducing an immune response
#864PMP proteins, gene sequences and uses thereof
#865PMP proteins, gene sequences and uses thereof
#866Compositions for reducing bacterial carriage and CNS invasion and methods of using same
#867Influenza antigens, vaccine compositions, and related methods
#868Pharmaceutical Compositions for Therapeutic Use
#869RECOMBINANT FRAGMENTS OF THE HUMAN ACETYLCHOLINE RECEPTOR AND THEIR USE FOR TREATMENT OF MYASTHENIA GRAVIS
#870Immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs
#871Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV)
#872Chimeric adenoviral vectors
#873SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF
#874Compositions that include hemagglutinin
#875Methods for preventing strokes by inducing tolerance to E-selectin
#876Attenuated bacteria
#877Vaccine against streptococci
#878Construction of live attenuated vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic
#879Intranasal or inhalational administration of virosomes
#880dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
#881Compositions that include hemagglutinin, methods of making and methods of use thereof
#882Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity
#883Mucosal meningococcal vaccines
#884Anthrax antigens and methods of use
#885Equine herpesvirus vaccine
#886Cold-adapted equine influenza viruses
#887Functional influenza virus like particles (VLPs)
#888Cold-adapted (CA) reassortant influenza virus
#889Method for assembling a polymer-biologic delivery composition
#890Anthrax vaccines and delivery methods
#891EDIBLE VACCINE
#892Signal for packaging of influenza virus vector
#893Influenza vaccine
#894Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
#895Immunogenic composition and methods
#896Fusogenic, self-propagating blebs as immunogenic compositions
#897Novel plant virus particles and methods of inactivation thereof
#898Peptide-based vaccine for influenza
#899Vaccine delivery
#900Compositions and methods for enhancing immunity by chemoattractant adjuvants